Morphine Slow-release Capsules in Substitution Therapy

PHASE3CompletedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Opiate Dependent
Interventions
DRUG

Sevre-Long™

The subjects will be randomised to either 10 weeks of treatment with methadone or SROM. After an adjustment phase of one week they first will be medicated for 10 weeks with the treatment to which they have been randomised. The cross-over, in which all subjects change to their opposite treatment, will serve for an additional adjustment phase of one week. After the second and new adjustment phase they are treated for 10 weeks with the newly adjusted medication. After the end of week 22 all participants continue with or switch back to SROM for another 6 month (week 23 to 47).

DRUG

Slow release oral morphine

DRUG

Methadone

Trial Locations (1)

Unknown

Zurich

All Listed Sponsors
lead

Mundipharma Medical Company

INDUSTRY

NCT01079117 - Morphine Slow-release Capsules in Substitution Therapy | Biotech Hunter | Biotech Hunter